(Q67809643)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:963686%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Integration of chemotherapy into combined modality treatment of solid tumors VII. Adenocarcinoma of the breast (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:963686%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference

1 reference

S. K. Carter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A963686

10 August 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=963686

10 August 2022

publication date

1 September 1976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:963686%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

published in

Cancer Treatment Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:963686%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:963686%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:963686%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

141-174

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:963686%20AND%20SRC:MED&resulttype=core&format=json

Cyclophosphamide in treatment of disseminated malignant disease.

17 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Five years clinical experience with 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Clinical appraisal of cyclophosphamide in malignant neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Treatment of Early Breast Cancer: A Report after Ten Years of a Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

VINBLASTINE SULPHATE IN THE TREATMENT OF MALIGNANT DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

A clinical review of bleomycin--a new antineoplastic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Adriamycin. A new anticancer drug with significant clinical activity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Hexamethylmelamine--a new drug with activity in solid tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Treatment of stage-II carcinoma of the female breast.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Treatment of stage-II carcinoma of the female breast

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Operable cancer of the breast.A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

The effects of the folic acid antagonists and 2,6-diaminopurine on neoplastic disease, with special reference to acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Single and combination nonhormonal chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Integration of chemotherapy into combined modality treatment of solid tumors. 1. The overall strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

The smaller the cancer, the bigger the operation? Rationale of small operations for small tumors and large operations for large tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

The case for local excision of breast cancer in selected cases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Radical mastectomy with parasternal and supraclavicular dissection for mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Five-drug therapy in advanced breast cancer: factors influencing toxicity and response

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Adjuvant chemotherapy in the radical treatment of carcinoma of the breast--a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Surgical adjuvant therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Cooperative clinical trials in primary breast cancer: A critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Cancer of the breast: Size of neoplasm and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

New concepts in the management of primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

THIOTEPA AND CYCLOPHOSPHAMIDE IN THE TREATMENT OF ADVANCED MAMMARY CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Summary of results obtained with CB 1348

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Is Radical Mastectomy the Optimal Procedure for Early Breast Carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Time and vehicle studies of a safe and effective method for administration of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Conservative Radical Mastectomy (Pateyʼs Operation)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Seventy-Five Cases of Solid Tumours Treated by a Modified Quadruple Chemotherapy Regime

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

A Method of Selecting Patients for Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Chemotherapy of solid carcinoma. Indications, agents, and results

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Treatment of cancer with weekly intravenous 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Hormone therapy in inoperable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

The role of 5-fluorouracil in malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

METAPLASIA IN OVARIAN DERMOIDS AND CYSTADENOMAS: REPORT OF THREE CASES

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Active immunotherapy for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Clinical trials with adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Carcinoma of the breast. A decade of new results with old concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Phase II evaluation of adriamycin in human neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Observations on the effects of the folic acid antagonists, aminopterin and amethopterin, in patients with advanced neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Therapeutic implications from a mathematical model characterizing the course of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Combination chemotherapy in disseminated carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Comparison of cyclophosphamide and 5-fluorouracil in the treatment of patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

An evaluation of therapeutic surgical castration in the treatment of metastatic, recurrent, and primary inoperable mammary carcinoma in women; an analysis of 191 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Selecting variations in extent of surgical procedure for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Clinical evaluation of cancer chemotherapy with 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Methotrexate for advanced cancer of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

TOXICITY AND ANTITUMOR EFFECT OF DIVIDED DOSES OF METHOTREXATE

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Cyclophosphamide therapy. Its use in leukemia, lymphoma and solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Cyclophosphamide-Induced Ovarian Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

MEANING OF FIVE-YEAR CURE IN CANCER OF THE BREAST

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

Chemotherapy of disseminated carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980020-5

7 January 2021

10.1016/S0305-7372(76)80020-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:963686%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference